Cost-Per-Number Needed To Treat (Nnt) Analysis Of Infliximab Compared To Adalimumab In The Treatment Of Moderate To Severe Ulcerative Colitis In The Brazilian Public Health Care System (Sus)
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1084
https://www.valueinhealthjournal.com/article/S1098-3015(13)01155-8/fulltext
Title :
Cost-Per-Number Needed To Treat (Nnt) Analysis Of Infliximab Compared To Adalimumab In The Treatment Of Moderate To Severe Ulcerative Colitis In The Brazilian Public Health Care System (Sus)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01155-8&doi=10.1016/j.jval.2013.03.1084
First page :
A214
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
657